Johnson & Johnson

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

We recently published a list of Top 9 AI News Updates Investors Probably Missed. In this article, we are going to take a look at where Koninklijke Philips N.V.'s (NYSE:PHG) stands against other top AI news updates investors probably missed.

Johnson & Johnson signed a multibillion-dollar contract with ChemImage in 2019. The two companies will face off in court next week.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

Discover why (NASDAQ:ZJK) is rated as a HOLD. Explore its growth in EV, AI, Aerospace markets, strong finances, and challenges ahead.

The new Microsoft Dragon Copilot solution leverages generative AI-powered ambient listening voice recognition to automate clinical documentation, enhance administrative efficiency and allow clinicians to focus on patient care. Kyndryl will begin offering Dragon Copilot in its healthcare services portfolio beginning in May 2025.

Johnson Controls is well-positioned with a robust $13.2 billion backlog and AI-driven solutions. Read what makes JCI stock an attractive long-term investment.

Equity markets have been volatile over the past week as some of the industry leaders in artificial intelligence (AI) -- which make up a large percentage of indexes like the Nasdaq Composite -- have been encountering stiff competition out of China.